du Plessis M, Smith A M, Klugman K P
Pneumococcal Diseases Research Unit of MRC, SAIMR, WITS, Department of Clinical Microbiology and Infectious Diseases, South African Institute for Medical Research, Johannesburg 2000, South Africa.
J Clin Microbiol. 1999 Mar;37(3):628-32. doi: 10.1128/JCM.37.3.628-632.1999.
A seminested PCR assay, based on the amplification of the pneumococcal pbp1A gene, was developed for the detection of penicillin resistance in clinical isolates of Streptococcus pneumoniae. The assay was able to differentiate between intermediate (MICs = 0.25 to 0.5 microgram/ml) and higher-level (MICs = >/=1 microgram/ml) resistance. Two species-specific primers, 1A-1 and 1A-2, which amplified a 1,043-bp region of the pbp1A penicillin-binding region, were used for pneumococcal detection. Two resistance primers, 1A-R1 and 1A-R2, were designed to bind to altered areas of the pbp1A gene which, together with the downstream primer 1A-2, amplify DNA from isolates with penicillin MICs of >/=0.25 and >/=1 microgram/ml, respectively. A total of 183 clinical isolates were tested with the pbp1A assay. For 98.3% (180 of 183) of these isolates, the PCR results obtained were in agreement with the MIC data. The positive and negative predictive values of the assay were 100 and 91%, respectively, for detecting strains for which the MICs were >/=0.25 microgram/ml and were both 100% for strains for which the MICs were >/=1 microgram/ml.
建立了一种基于肺炎球菌pbp1A基因扩增的半巢式PCR检测方法,用于检测肺炎链球菌临床分离株中的青霉素耐药性。该检测方法能够区分中度耐药(MICs = 0.25至0.5微克/毫升)和高度耐药(MICs >=1微克/毫升)。两种物种特异性引物1A-1和1A-2用于肺炎球菌检测,它们扩增pbp1A青霉素结合区的一个1043bp区域。设计了两种耐药引物1A-R1和1A-R2,使其与pbp1A基因的变异区域结合,这两种引物与下游引物1A-2一起,分别从青霉素MICs >=0.25微克/毫升和>=1微克/毫升的分离株中扩增DNA。使用pbp1A检测方法对总共183株临床分离株进行了检测。对于其中98.3%(183株中的180株)的分离株,获得的PCR结果与MIC数据一致。该检测方法检测MICs >=0.25微克/毫升菌株的阳性预测值和阴性预测值分别为100%和91%,检测MICs >=1微克/毫升菌株的阳性预测值和阴性预测值均为100%。